Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR)
Background: TAVR has emerged as an attractive alternative for treatment of severe aortic stenosis in high risk surgical patients. Despite several large multicenter registries, only one randomized trial (PARTNER) has been published. Objective: We aimed to compare the outcomes obtained using multicent...
Main Authors: | Shikhar Agarwal, E. Murat Tuzcu, William Stewart, Navkaranbir Singh Bajaj, Lars G. Svensson, Samir R. Kapadia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-07-01
|
Series: | Indian Heart Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483213001879 |
Similar Items
-
Will Transcatheter Aortic Valve Replacement (TAVR) be the Primary Therapy for Aortic Stenosis?
by: Jose F. Condado, MD, MS, et al.
Published: (2016-05-01) -
Early results from an Egyptian transcatheter aortic valve registry (Egy-TVR)
by: Hesham Bahaa, et al.
Published: (2021-07-01) -
Early- and mid-term outcomes after transcatheter aortic valve implantation. Data from a single-center registry
by: Maciej Bagienski, et al.
Published: (2016-05-01) -
Update on Transcatheter Aortic Valve Replacement
by: Morgan H. Randall, et al.
Published: (2020-02-01) -
Multicenter experience with a second-generation fully-retrievable and repositionable transcatheter aortic valve
by: Daniele Gemma, et al.
Published: (2020-05-01)